Latest Omega Fund Management, LLC Stock Portfolio
Omega Fund Management, LLC Performance:
2025 Q1: -11.05%YTD: -11.05%2024: 17.8%
Performance for 2025 Q1 is -11.05%, and YTD is -11.05%, and 2024 is 17.8%.
About Omega Fund Management, LLC and 13F Hedge Fund Stock Holdings
Omega Fund Management, LLC is a hedge fund based in BOSTON, MA. On 12-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Omega Fund Management, LLC reported an equity portfolio of $169.5 Millions as of 31 Mar, 2025.
The top stock holdings of Omega Fund Management, LLC are , , . The fund has invested 26.4% of it's portfolio in KESTRA MED TECHNOLOGIES LTD. and 17% of portfolio in BICARA THERAPEUTICS INC.
The fund managers got completely rid off SYROS PHARMACEUTICALS (SYRS) stocks. Omega Fund Management, LLC opened new stock positions in KESTRA MED TECHNOLOGIES LTD..
The top stock holdings of Omega Fund Management, LLC are , , . The fund has invested 26.4% of it's portfolio in KESTRA MED TECHNOLOGIES LTD. and 17% of portfolio in BICARA THERAPEUTICS INC.
The fund managers got completely rid off SYROS PHARMACEUTICALS (SYRS) stocks. Omega Fund Management, LLC opened new stock positions in KESTRA MED TECHNOLOGIES LTD..
Omega Fund Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Omega Fund Management, LLC made a return of -11.05% in the last quarter. In trailing 12 months, it's portfolio return was -19.17%.
New Buys
| Ticker | $ Bought |
|---|---|
| kestra med technologies ltd. | 44,753,700 |
| beta bionics inc. | 24,336,600 |
New stocks bought by Omega Fund Management, LLC
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| syros pharmaceuticals | -57,792 |
Omega Fund Management, LLC got rid off the above stocks
Sector Distribution
Omega Fund Management, LLC has about 71.4% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 71.4 |
| Healthcare | 28.6 |
Market Cap. Distribution
Omega Fund Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 71.4 |
| SMALL-CAP | 25.8 |
| MICRO-CAP | 2.8 |
Stocks belong to which Index?
About 27.5% of the stocks held by Omega Fund Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 72.5 |
| RUSSELL 2000 | 27.5 |
Omega Fund Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Omega Fund Management, LLC
Omega Fund Management, LLC has 13 stocks in it's portfolio. About 97.9% of the portfolio is in top 10 stocks. NUVB proved to be the most loss making stock for the portfolio. IMUX was the most profitable stock for Omega Fund Management, LLC last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| kestra med technologies ltd. | 26.41 | 1,795,890 | 44,753,700 | new | ||||
| bicara therapeutics inc. | 16.95 | 2,204,650 | 28,726,600 | unchanged | 0.00 | |||
| beta bionics inc. | 14.36 | 1,988,290 | 24,336,600 | new | ||||
| NUVB | nuvation bio | 13.58 | 13,072,300 | 23,007,300 | unchanged | 0.00 | ||
| REPL | replimune group | 11.36 | 1,975,200 | 19,258,200 | unchanged | 0.00 | ||
| upstream bio inc. | 7.35 | 2,036,290 | 12,462,100 | unchanged | 0.00 | |||
| lexeo therapeutics | 2.43 | 1,184,640 | 4,110,690 | unchanged | 0.00 | |||
| alumis inc. | 2.37 | 653,223 | 4,010,790 | unchanged | 0.00 | |||
| IKNA | ikena oncology | 1.70 | 2,249,120 | 2,878,880 | unchanged | 0.00 | ||
| engene holdings inc. | 1.39 | 526,357 | 2,358,080 | unchanged | 0.00 | |||
| IMUX | immunic inc. | 1.15 | 1,788,160 | 1,949,090 | unchanged | 0.00 | ||
| SANA | sana biotechnology, inc. | 0.84 | 843,750 | 1,417,500 | unchanged | 0.00 | ||
| engene holdings inc. | 0.11 | 321,502 | 192,901 | unchanged | 0.00 | |||
| SYRS | syros pharmaceuticals | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
